Security
ZyVersa Therapeutics, Inc. Com Par $0.001 · ZVSA
ZVSAOTCCommon stockHistorical · closed Oct 19, 2026CIK 1859007Updated Oct 6, 2026
Name history
Larkspur Health Acquisition Corp. · through Dec 9, 2022
Current security for this SEC filerZVSA · OTC
ZVSA price & chart
Historical security
This listing closed Oct 19, 2026. Live provider charts are shown only for current listings.
Current security: ZVSA
In the news
Seeking Alpha
ZyVersa Therapeutics GAAP EPS of -$4.18 ↗
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 1,040,260Source | 19,423,924Source | 32,852,009Source | 19,641,111Source | 19,469,504Source | 742,223Source | 20,985,541Source | 21,650,764Source | 347,901Source | 20,599,414Source | 22,114,284Source | 118,506,271Source |
| Property, Plant and EquipmentUSD | — | — | 9,533Source | — | 1,733Source | — | — | 4,333Source | — | — | 6,933Source | 17,333Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | — | 11,895,033Source |
| Current assets: | ||||||||||||
| Assets, CurrentUSD | 995,533Source | 390,415Source | 2,005,240Source | 549,069Source | 641,392Source | 742,223Source | 2,110,310Source | 2,900,052Source | 347,901Source | 1,715,797Source | 3,353,133Source | 6,362,546Source |
| Prepaid Expense and Other Assets, CurrentUSD | 298,192Source | 267,494Source | 426,519Source | 378,749Source | 521,906Source | 439,563Source | 498,778Source | 866,476Source | 231,639Source | 184,873Source | 215,459Source | — |
| Operating Lease, Right-of-Use AssetUSD | — | — | 31,078Source | — | — | — | — | — | — | — | 7,839Source | 98,371Source |
| Other Assets, NoncurrentUSD | — | 18,647,903Source | — | — | 18,647,903Source | — | 18,647,903Source | 18,647,903Source | — | 18,647,903Source | 18,647,903Source | 100,086,329Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 12,765,827Source | 12,396,624Source | 13,148,350Source | 13,541,337Source | 10,849,449Source | 14,866,518Source | 12,855,191Source | 10,427,630Source | 12,734,687Source | 12,082,967Source | 11,039,686Source | 18,511,943Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | — | — | — | — | — | — | — | — | — | 1Source | — |
| Common Stock, Value, IssuedUSD | 809Source | 107Source | 4,353Source | 487Source | 83Source | 809Source | 257Source | 83Source | 809Source | 251Source | 405Source | 902Source |
| Additional Paid in CapitalUSD | 125,187,156Source | 118,245,220Source | 109,587,097Source | 123,207,260Source | 117,436,743Source | 125,260,381Source | 123,026,749Source | 117,276,079Source | 125,204,509Source | 121,155,922Source | 114,300,484Source | 104,583,271Source |
| Retained Earnings (Accumulated Deficit)USD | -136,906,365Source | -111,210,860Source | -89,880,624Source | -117,100,806Source | -108,809,604Source | -139,378,318Source | -114,889,489Source | -106,045,861Source | -137,584,937Source | -112,632,559Source | -103,219,124Source | -4,921,178Source |
| Stockholders' Equity Attributable to ParentUSD | -11,725,567Source | 7,027,300Source | 19,703,659Source | 6,099,774Source | 8,620,055Source | -14,124,295Source | 8,130,350Source | 11,223,134Source | -12,386,786Source | 8,516,447Source | 11,074,598Source | 99,662,997Source |
| Liabilities and EquityUSD | 1,040,260Source | 19,423,924Source | 32,852,009Source | 19,641,111Source | 19,469,504Source | 742,223Source | 20,985,541Source | 21,650,764Source | 347,901Source | 20,599,414Source | 22,114,284Source | 118,506,271Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 12,765,827Source | 11,542,003Source | 11,707,368Source | 12,689,678Source | 9,994,828Source | 14,866,518Source | 12,003,532Source | 9,582,716Source | 12,734,687Source | 11,231,308Source | 10,194,772Source | 8,187,960Source |
| Operating Lease, Liability, CurrentUSD | — | — | 34,349Source | — | — | — | — | — | — | — | 8,656Source | 108,756Source |
| Accounts Payable, CurrentUSD | 9,805,129Source | 9,284,631Source | 8,897,534Source | 9,774,230Source | 8,316,506Source | 10,235,276Source | 9,604,568Source | 8,127,746Source | 10,123,391Source | 9,337,267Source | 8,431,583Source | 6,025,645Source |
| Deferred Income Tax Liabilities, NetUSD | — | 854,621Source | 1,440,982Source | 851,659Source | 854,621Source | — | 851,659Source | 844,914Source | — | 851,659Source | 844,914Source | 10,323,983Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 2,960,698Source | 2,257,372Source | 2,775,485Source | 2,915,448Source | 1,678,322Source | 3,303,242Source | 2,398,964Source | 1,454,970Source | 2,611,296Source | 1,894,041Source | 1,754,533Source | 2,053,559Source |
| Intangible Assets, Net (Excluding Goodwill) | — | — | —Source | — | — | — | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 55,872Source | 153,891Source | 222,831Source | 705,567Source | 1,192,963Source | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 111,885Source | 191,445Source | 689,268Source | 750,569Source | 2,405,938Source | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -799,118Source | -1,772,052Source | -5,114,381Source | -7,559,697Source | -8,720,819Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,000,000Source | 1,852,660Source | 3,685,235Source | 5,952,947Source | 5,956,294Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 200,882Source | 80,608Source | -1,429,146Source | -1,606,750Source | -2,764,525Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 527,978Source | 122,921Source | 72,086Source | 119,486Source | 302,660Source | 1,611,532Source | 101,778Source | 1,530,924Source | 3,137,674Source | 5,902,199Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 73,988Source | 160,665Source | 59,199Source | 160,664Source | 55,872Source | 72,291Source | 222,831Source | 705,567Source | 1,192,963Source | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | 6,933Source | 10,400Source | — |
| General and Administrative ExpenseUSD | — | — | 1,739,174Source | 1,833,578Source | 1,634,195Source | 2,044,929Source | 1,247,077Source | 1,885,695Source | 5,731,682Source | 7,357,559Source | 11,213,201Source | — |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | — | 11,895,033Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 11,895,033Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | 81,438,426Source | — |
| Income Tax Expense (Benefit)USD | — | — | -851,659Source | — | — | 9,707Source | — | — | -851,659Source | 6,745Source | -9,455,830Source | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -19,805,559Source | -2,401,256Source | -2,211,317Source | -2,763,743Source | -1,793,381Source | -2,256,930Source | -24,952,378Source | -9,413,435Source | -98,297,946Source | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,401,256Source | — | -2,763,743Source | — | — | — | -9,413,435Source | -106,246,155Source | — |
| Operating ExpensesUSD | — | — | 20,752,130Source | 2,269,621Source | 2,044,132Source | 2,753,978Source | 1,304,698Source | 2,144,571Source | 25,492,690Source | 9,136,834Source | 107,754,233Source | — |
| Payments of Financing CostsUSD | — | — | 175,221Source | 427,054Source | — | — | 282,849Source | 282,849Source | 290,317Source | 212,102Source | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | 1,354,404Source | — | — |
| Proceeds from (Payments for) Other Financing Activities | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -20,752,130Source | -2,269,621Source | -2,044,132Source | -2,753,978Source | -1,304,698Source | -2,144,571Source | -25,492,690Source | -9,136,834Source | -107,754,233Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -20,657,218Source | -2,401,256Source | -2,211,317Source | -2,754,036Source | — | — | -25,804,037Source | -9,406,690Source | -107,753,776Source |
| Income Tax Expense (Benefit)USD | — | — | -851,659Source | — | — | 9,707Source | — | — | -851,659Source | 6,745Source | -9,455,830Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -19,805,559Source | -2,401,256Source | -2,211,317Source | -2,763,743Source | -1,793,381Source | -2,256,930Source | -24,952,378Source | -9,413,435Source | -98,297,946Source |
| Earnings Per Share, BasicUSD per share | — | — | -2.56Source | -2.43Source | -0.46Source | -3.31Source | -0.22Source | -0.73Source | -4.18Source | -8.48Source | -108.97Source |
| Earnings Per Share, DilutedUSD per share | — | — | -2.56Source | -2.43Source | -0.46Source | -3.31Source | -0.22Source | -0.73Source | -4.18Source | -8.48Source | -108.97Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 7,740,678Source | 988,378Source | 4,814,115Source | 834,915Source | 8,095,921Source | 3,106,928Source | 5,963,943Source | 1,110,033Source | 975,035Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 7,740,678Source | 988,378Source | 4,814,115Source | 834,915Source | 8,095,921Source | 3,106,928Source | 5,963,943Source | 1,110,033Source | 975,035Source |
| Additional Financial Items | |||||||||||
| General and Administrative ExpenseUSD | — | — | 1,739,174Source | 1,833,578Source | 1,634,195Source | 2,044,929Source | 1,247,077Source | 1,885,695Source | 5,731,682Source | 7,357,559Source | 11,213,201Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 11,895,033Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -25,804,037Source | — | — |
| Interest Income (Expense), NetUSD | — | — | -131,350Source | -131,635Source | -130,036Source | -58Source | -132,512Source | -119,559Source | -513,209Source | -269,856Source | 457Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | -2,401,256Source | — | -2,763,743Source | — | — | — | -9,413,435Source | -106,246,155Source |
| Operating ExpensesUSD | — | — | 20,752,130Source | 2,269,621Source | 2,044,132Source | 2,753,978Source | 1,304,698Source | 2,144,571Source | 25,492,690Source | 9,136,834Source | 107,754,233Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | — | — | — | — | — | — | — | — | — | 32,373Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | — | — | — | 7,948,209Source |
| Research and Development ExpenseUSD | — | — | 365,053Source | 436,043Source | 409,937Source | 709,049Source | 57,621Source | 258,876Source | 1,113,105Source | 1,779,275Source | 3,207,573Source |